Synaffix - A Lonza Company

Synaffix has established a proprietary, clinical-stage platform antibody-drug conjugate (ADC) technology that delivers superior safety and efficacy compared to all 3 major clinical-stage ADC technologies. Our business model is technology out-licensing.

Address

Oss
Netherlands
Visit website (opens in a new tab)
Loading